May 4, 2016 | NEWS
Analyzes whole genome and detailed clinical data from nearly 300,000 Icelanders Finds several novel variations in the sequence of the human genome modulating cholesterol levels Five variants are also causally linked to increased risk of coronary artery disease Shows...
Jun 8, 2015 | NEWS
A multinational study of data from 130,000 people shows that inherited risk factors for schizophrenia and bipolar disorder also predict participation in the arts and creative professions REYKJAVIK, Iceland, 8 June 2015 – A study led by scientists at deCODE genetics...
Mar 25, 2015 | NEWS
The largest studies of whole-genome data ever published reveal the power of the sequencing revolution for understanding the roots of disease, diversity and evolution: The most comprehensive population-wide tally to date of sequence variation A nationwide collection of...
Dec 18, 2013 | NEWS
REYKJAVIK, Iceland, Dec. 18, 2013 – deCODE genetics, a global leader in analyzing and understanding the human genome, reported today in the journal Nature that mutations associated with an increased risk of schizophrenia and autism also affect cognition in...
May 5, 2013 | NEWS
Nature Published Study Illustrates Value of Big Data Research Methods deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University...
Dec 12, 2012 | NEWS
deCODE Genetics Will Provide Amgen With an Industry-Leading Ability to Identify and Validate Disease Targets in Human Populations THOUSAND OAKS, Calif. and REYKJAVIK, Iceland, Dec. 10, 2012 /PRNewswire/ — Amgen (NASDAQ:AMGN) and deCODE Genetics today announced...
